It’s a different product with different uses and the pharma that are and is looking at it is not effected by the delay of dx-1 for them to start using for their own disciplines
Think you need to stop guessing Duke and start speaking to people who know what the go is..
The future is not as doom and gloom as some might think
Ann: Appendix 4C - Quarterly - 31 March 2023, page-62
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 154511 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 4813825 | 5 |
View Market Depth
| Last trade - 16.12pm 31/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable